Clinical Trials Directory

Trials / Completed

CompletedNCT02992067

CK19 Combined With Contrast-enhanced Ultrasound: a Prediction System on Axillary Lymph Node Metastasis in Breast Cancer

Status
Completed
Phase
Study type
Observational
Enrollment
359 (actual)
Sponsor
Zhejiang Cancer Hospital · Academic / Other
Sex
Female
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To establish a predicting system on axillary lymph node metastasis based on peripheral blood CK19mRNA and contrast-enhanced ultrasound.

Detailed description

The feasibility and predictive accuracy of peripheral blood CK19mRNA and contrast-enhanced ultrasound of axillary lymph nodes metastasis in breast cancer were verified by the data of specimen bank; to establish the evaluation system of predicting the lymph node status based on CK19 and CEUS, validate the sensitivity, specificity, negative predictive value, positive predictive value and ROC curve of the system model and use Youden index, negative likelihood ratio, positive likelihood ratio to evaluate the diagnostic efficiency.

Conditions

Timeline

Start date
2015-04-01
Primary completion
2017-04-01
Completion
2017-07-01
First posted
2016-12-14
Last updated
2019-10-04
Results posted
2019-10-04

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02992067. Inclusion in this directory is not an endorsement.